Ping An Insurance (Group) Company of China (2318) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
23 Jan, 2026Executive summary
Revenue increased by 1.5% year-over-year to RMB554.1 billion, with net profit up 6.8% to RMB74.6 billion and operating profit attributable to shareholders at RMB78.5 billion, down 0.6% year-on-year.
Annualized operating ROE was 16.4%, reflecting high capital efficiency.
Interim dividend maintained at RMB0.93 per share, demonstrating a stable payout and focus on shareholder returns.
Life & Health NBV grew 11.0% to RMB22.3 billion, with agent channel NBV up 10.8% and NBV per agent up 36.0%.
Property & Casualty insurance revenue increased 3.9% to RMB161.9 billion, with a combined ratio of 97.8%.
Financial highlights
Total assets reached RMB12,226,666 million, up 5.6% year-to-date; equity attributable to shareholders rose to RMB931,208 million, up 3.6%.
Group comprehensive solvency margin ratio at 208.8%, well above regulatory requirements.
Life & Health operating ROE was 29.4%; Property & Casualty operating ROE at 15.2%; Banking at 11.9%.
Embedded value of Life & Health rose 10.3% year-to-date to RMB916,230 million.
Net investment yield was 3.3%, with a comprehensive investment yield of 4.2%.
Outlook and guidance
Management expects continued economic recovery in China, focusing on core businesses, digital transformation, and integrated finance plus health and senior care strategy.
Strategic priorities include agent force stabilization, customer value system upgrades, and leveraging technology for growth.
Company remains committed to stable dividends and high-quality, resilient growth.
Lufax Holding to become a consolidated subsidiary post-period, with no material impact expected on financial position.
Anticipates further expansion of health and senior care services, leveraging demographic trends.
Latest events from Ping An Insurance (Group) Company of China
- Net profit up 47.8%, Life & Health NBV up 28.8%, and dividends rose for the 13th year.2318
H2 20245 Jan 2026 - Net profit jumped 36.1% YoY, with robust growth across core insurance and banking segments.2318
Q3 20242 Dec 2025 - OPAT up 2.4% YoY, L&H NBV up 34.9%, solvency ratios robust, net profit down 26.4%.2318
Q1 20252 Dec 2025 - Operating profit up 3.7% YoY, Life & Health NBV up 39.8%, interim dividend up 2.2%.2318
Q2 20252 Dec 2025 - Net profit rose 11.5% YoY, driven by strong insurance, investment, and digital performance.2318
Q3 20252 Dec 2025